Macular degeneration treatment

Macular degeneration treatment

C026/6364 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.3MB

Downloadable file size: 14.3MB

Price image Pricing

Please login to use the price calculator



Caption: Macular degeneration treatment. 75-year-old female patient receiving an intra-ocular bevacizumab (Avastin) injection to treat macular degeneration and retinal vein thrombosis. Bevacizumab is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. It is usually used in chemotherapy to treat a number of cancers but here is being used to treat age-related eye conditions. Macular degeneration caused damage to the macula, the central area of the retina in the eye, which leads to a loss of vision in the central field of vision. Retinal vein thrombosis, or central retinal vein occlusion, is a blockage of the central retinal vein. As one of only two sources of blood supply to the eye, occlusion of the central retinal vein can lead to blindness.

Release details: Model release not required. Property release not required.

Keywords: 75, 75-year-old, 75-years-old, abnormal, adult, age-related, angiogenesis inhibitor, avastin, bevacizumab, blockage, blocked, caucasian, central retinal vein occlusion, close-up, condition, detail, disease, diseased, disorder, doctor, drug, drugs, elderly, eye, eyeball, female, healthcare, hospital, human, injecting, injection, intra-ocular, intraocular, macula, macular degeneration, medical, medicine, occluded, ocular, old, older, ophthalmic, ophthalmological, ophthalmologist, ophthalmology, patient, person, retina, retinal, retinal vein thrombosis, seventies, sight, treating, treatment, two people, unhealthy, vision, white, woman

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.